Abstract
Cyclooxygenase plays a pivotal role in the transformation of the arachidonic acid to prostaglandins (PGs) and thromboxane. It is composed of two kinds of enzymes, namely cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX- 2). Cyclooxygenase 1 is the constructive enzyme whereas the cyclooxygenase 2 is the inducible enzyme. Inhibiting cyclooxygenase 1 is always associated with some undesirable side-effects, while inhibiting cyclooxygenase 2 can result in therapeutic effect. This has led the researchers to strive for searching the selective inhibitors inhibiting the COX-2 instead of COX-1. It is very well known that pain and inflammation are alleviated through the inhibition of COX-2 inhibitors such as Aspirin, which has resulted in the recent years, in the emergence of a range of COX-2 inhibitors. Moreover, while evaluating the functions of the COX-2 inhibitions, their significant role in treating glaucoma, preventing and suppressing cancer through their inhibitory activity was clearly revealed and many studies further demonstrated that COX-2 is not only related to the inflammation of peripheral tissues but also to the inflammation manifested in the central nervous system. In addition, the nervous disorders also found an effective treatment with the administration of COX-2 inhibitors. The above-mentioned findings delineate the role of the COX-2 inhibitors as promising agents to be exploited in the treatment of many illnesses. This review will elucidate the functions of the COX-2 inhibitors briefly and introduce some common selective inhibitors of COX-2.
Keywords: Anti-Inflammation, prostaglandin I2, Celecoxib, glaucoma, Anti-prostate Cancer, neurological Diseases
Mini-Reviews in Medicinal Chemistry
Title: The Function of the Selective Inhibitors of Cycloxygenase 2
Volume: 6 Issue: 12
Author(s): Yepeng Luan and Wenfang Xu
Affiliation:
Keywords: Anti-Inflammation, prostaglandin I2, Celecoxib, glaucoma, Anti-prostate Cancer, neurological Diseases
Abstract: Cyclooxygenase plays a pivotal role in the transformation of the arachidonic acid to prostaglandins (PGs) and thromboxane. It is composed of two kinds of enzymes, namely cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX- 2). Cyclooxygenase 1 is the constructive enzyme whereas the cyclooxygenase 2 is the inducible enzyme. Inhibiting cyclooxygenase 1 is always associated with some undesirable side-effects, while inhibiting cyclooxygenase 2 can result in therapeutic effect. This has led the researchers to strive for searching the selective inhibitors inhibiting the COX-2 instead of COX-1. It is very well known that pain and inflammation are alleviated through the inhibition of COX-2 inhibitors such as Aspirin, which has resulted in the recent years, in the emergence of a range of COX-2 inhibitors. Moreover, while evaluating the functions of the COX-2 inhibitions, their significant role in treating glaucoma, preventing and suppressing cancer through their inhibitory activity was clearly revealed and many studies further demonstrated that COX-2 is not only related to the inflammation of peripheral tissues but also to the inflammation manifested in the central nervous system. In addition, the nervous disorders also found an effective treatment with the administration of COX-2 inhibitors. The above-mentioned findings delineate the role of the COX-2 inhibitors as promising agents to be exploited in the treatment of many illnesses. This review will elucidate the functions of the COX-2 inhibitors briefly and introduce some common selective inhibitors of COX-2.
Export Options
About this article
Cite this article as:
Luan Yepeng and Xu Wenfang, The Function of the Selective Inhibitors of Cycloxygenase 2, Mini-Reviews in Medicinal Chemistry 2006; 6 (12) . https://dx.doi.org/10.2174/138955706778992969
DOI https://dx.doi.org/10.2174/138955706778992969 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Comprehensive Comparison of Trace Metal Concentrations in Cancerous and Non-Cancerous Human Tissues
Current Medicinal Chemistry A Review of the Chemical and Pharmacological Aspects of the Genus Marrubium
Current Pharmaceutical Design From French Paradox to Cancer Treatment: Anti-cancer Activities and Mechanisms of Resveratrol
Anti-Cancer Agents in Medicinal Chemistry Distinct Epigenetic Reprogramming, Mitochondrial Patterns, Cellular Morphology, and Cytotoxicity after Bee Venom Treatment
Recent Patents on Anti-Cancer Drug Discovery Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers
Current Medicinal Chemistry Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells
Current Cancer Therapy Reviews Phosphonomethoxyalkyl Analogs of Nucleotides
Current Pharmaceutical Design Advances in Clinical Study of Curcumin
Current Pharmaceutical Design Preclinical Evidence on the Anticancer Properties of Food Peptides
Protein & Peptide Letters Is There an Increased Risk of Lymphoma and Malignancies Under Anti- TNF Therapy in IBD?
Current Drug Targets Cyclooxygenases in Cancer: Chemoprevention and Sensitization to Conventional Therapies
Mini-Reviews in Medicinal Chemistry Pharmaceutical Perspectives of HECT-TYPE Ubiquitin Ligase Smurf1
Current Pharmaceutical Design Phosphorothioate Oligonucleotides: Effectiveness and Toxicity
Current Drug Targets Small Molecular Inhibitors of p-STAT3: Novel Agents for Treatment of Primary and Metastatic CNS Cancers
Recent Patents on CNS Drug Discovery (Discontinued) Transition Metal Based Anticancer Drugs
Current Topics in Medicinal Chemistry A Dual Mode Pulsed Electro-Magnetic Cell Stimulator Produces Acceleration of Myogenic Differentiation
Recent Patents on Biotechnology Immunogenic Issues Concerning Recombinant Adeno-Associated Virus Vectors for Gene Therapy
Current Gene Therapy Anticancer Properties of Amino Acid and Peptide Derivatives of Mycophenolic Acid
Anti-Cancer Agents in Medicinal Chemistry Targeting Therapeutic and Imaging Agents to Folate Receptor Positive Tumors
Current Pharmaceutical Biotechnology Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions
Current Drug Targets